Literature DB >> 9372508

Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin.

M Kaufman1.   

Abstract

Two patients who were taking warfarin experienced significant prolongations of the prothrombin time (protime) after treatment with high-dose corticosteroids for rapid progression of MS. This complication of therapy is potentially life-threatening.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9372508     DOI： 10.1177/135245859700300406

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


  4 in total

1.  Combination of lenalidomide and low-dose dexamethasone therapy promotes the anticoagulant activity of warfarin in patients with immunoglobulin light-chain amyloidosis.

Authors:  Fumiaki Kitazawa; Shin-Ichi Fuchida; Fumitaka Ise; Yoko Kado; Kumi Ueda; Takatoshi Kokufu; Akira Okano; Mayumi Hatsuse; Satoshi Murakami; Yuko Nakayama; Kohji Takara; Chihiro Shimazaki
Journal:  Oncol Lett       Date:  2017-05-08       Impact factor: 2.967

2.  Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial.

Authors:  Mary Beth Dowd; Kellie A Vavra; Daniel M Witt; Thomas Delate; Kerri Martinez
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

3.  Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism.

Authors:  Xiaowei Gong; Haiyan Wang; Yadong Yuan
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

Review 4.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.